Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Impact of COVID-19 Pandemic on Depression and Quality of Life

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04394078
Recruitment Status : Completed
First Posted : May 19, 2020
Last Update Posted : June 11, 2020
Sponsor:
Collaborator:
Yuksek Ihtisas University
Information provided by (Responsible Party):
Begüm Okudan, Okan University

Brief Summary:
It is aimed to investigate the depression and quality of life of Turkish society caused by Covid-19 pandemic and reveal the relationship between them

Condition or disease Intervention/treatment
Depression Quality of Life Covid 19 Social Isolation Other: Online survey

Detailed Description:
Study hypothesis that people are tend to be depressed and the quality of life is affected negatively by Covid-19 pandemic. Although Turkey has affected moderately, the immediate change on depression and quality of life observable and measurable. It is aimed to investigate the depression and quality of life of Turkish society caused by Covid-19 pandemic and reveal the relationship between them. According to existing data and perspective of psychology and physiotherapy, potential solutions will be aligned.

Layout table for study information
Study Type : Observational
Actual Enrollment : 543 participants
Observational Model: Ecologic or Community
Time Perspective: Cross-Sectional
Official Title: Impact of COVID-19 Pandemic on Depression and Quality of Life: Cross Sectional Study on Turkish Society and Suggestions on Potential Solution
Actual Study Start Date : May 6, 2020
Actual Primary Completion Date : May 18, 2020
Actual Study Completion Date : May 18, 2020

Resource links provided by the National Library of Medicine


Group/Cohort Intervention/treatment
Turkish society
Individuals speak Turkish and lives in Turkey, ages between 15 - 65, literate and with internet access
Other: Online survey
Volunteer individuals enrolled the study after approval an online informed consent form. Sociodemographic data of the participants recorded as an online survey. Then, patient reported outcomes were used to assess depression (Zung depression Scale) and quality of life (WHO Qualiy of Life - Bref version).




Primary Outcome Measures :
  1. Sociodemographic information form [ Time Frame: two months after Covid 19 recognised as pandemic ]
    Participants are asked to give information about: age, gender, educational status, height, weight, occupation, working status, city inhabited, whether they live alone or with someone, whether they have a chronic disease, have a pet, do physical activity, eat healthy and sufficient, have qualified sleep, whether they are supported economically.

  2. Zung Depression Scale [ Time Frame: two months after Covid 19 recognised as pandemic ]
    Zung depression scale, developed by Zung (Zung, 1965), is patient rating depression scale, was used to asses four domains related to depression; somatic, mood disorders, psychomotor and psychological disorders. Each question is rated on a 4-point Likert scale (0- never, 1- sometimes, 2- frequently, 3- always). Scale contains 10 straight 10 reverse questions. The total score is calculated from the raw score obtained (total score = (raw score / 80) * 100). Accordingly, scores less than 50 are normal or no psychopathology; between 50 and 59 points indicates mild level, between 60 and 69 points indicate moderate level and 70 and above points indicate severe level depression (Thurber et al., 2002). The validity reliability of the scale was studied on Turkish society (Gencdogan & Nihal, 2011)

  3. World Health Organization Quality of Life - Bref [ Time Frame: two months after Covid 19 recognised as pandemic ]
    World Health Organization Quality of Life Bref is the short version of the WHOQOL-100 to assess the health-related quality of life (Harper et al., 1998), which has efficient psychometric properties, valid and reliable for Turkish society (Eser et al., 1999). It is essential for epidemiological survey and international report has built for psychometric properties for 26 country where Turkey within (Skevington et al., 2004). It has 4 domains; physical health, psychology, social relations and environment. Each question is answered on a 5-point Likert scale. The raw score is converted into a percentage system. The quality of life is interpreted as good as it gets closer to 100% (Akvardar et al., 2006).



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   15 Years to 65 Years   (Child, Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
The population of the individuals between 15 - 65 ages in Turkey is 56.391.925 people. It is calculated that there are 42.463.119 individuals cover the criterion as universe of the study.
Criteria

Inclusion Criteria:

  • being Turkish
  • understanding Turkish
  • currently living in Turkey
  • being between the age of 15 - 65
  • being literate
  • have internet access

Exclusion Criteria:

  • being diagnosed with a psychological disorder before the pandemic
  • having missing value on outcome measures
  • giving incomprehensible answering

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04394078


Locations
Layout table for location information
Turkey
Okan University
Istanbul, Turkey, 34959
Sponsors and Collaborators
Okan University
Yuksek Ihtisas University
Layout table for additonal information
Responsible Party: Begüm Okudan, MSc. Pt, Okan University
ClinicalTrials.gov Identifier: NCT04394078    
Other Study ID Numbers: 56665618-204.01.07
First Posted: May 19, 2020    Key Record Dates
Last Update Posted: June 11, 2020
Last Verified: June 2020
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No
Plan Description: Data are stored by researches, if needed for scientific purposes, it can be discussed to share .

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Begüm Okudan, Okan University:
Covid 19
Depression
Quality of Life
Turkish Society
Social Isolation
Additional relevant MeSH terms:
Layout table for MeSH terms
Depression
Depressive Disorder
Behavioral Symptoms
Mood Disorders
Mental Disorders